Brussels, 9 July 2025 – The European Confederation of Pharmaceutical Entrepreneurs (EUCOPE) reckons both the EU Medical Countermeasures and Stockpiling Strategies, published today, as positive steps toward improving the EU’s preparedness for future health emergencies. In an increasingly uncertain geopolitical scenario, strengthening the EU medical… read more
Brussels, 2 July 2025 – The European Confederation of Pharmaceutical Entrepreneurs (EUCOPE) appreciates and supports the European Commission’s ambition to strengthen the EU’s healthcare ecosystem through a comprehensive EU Life Sciences Strategy. A more integrated and innovation-friendly regulatory framework is essential for the EU to… read more
Brussels, 5 June 2025 – Following the negotiators in the Council having agreed their General Approach yesterday (4 June), the European Confederation of Pharmaceutical Entrepreneurs (EUCOPE) acknowledges the step forward in the legislative process and urges EU policymakers to safeguard the EU’s innovation-driven life sciences… read more
16 April 2025, Geneva – The International Federation of Pharmaceutical Manufacturers and Associations (IFPMA), representing the innovative pharmaceutical industry worldwide, and the European Confederation of Pharmaceutical Entrepreneurs (EUCOPE), representing small and mid-sized innovative health technology companies in Europe, welcome and echo the Call… read more
ARM, EFPIA, EUCOPE, EuropaBio, Vaccines Europe From 12 January 2025 the Regulation (EU) 2021/2282 on health technology assessment will apply and the first Joint Clinical Assessments (JCA) will be performed to assess the relative clinical effectiveness of new innovative cancer therapies and cell and gene… read more
A new college of Commissioners All signs point towards the need for a more competitive environment for pharmaceutical R&D in Europe. In this context, EUCOPE extends its congratulations to the newly appointed European Commissioners, whose mandates will deliver on large-scale change initiated under the last… read more
Brussels, 15 November 2023 Today, EUCOPE and FTI Consulting EU published a report titled The Economic Lens: Understanding What Makes the EU Attractive for Life Sciences Investments. The report provides an analysis of the current environment in the EU for attracting life sciences investments and… read more
On Tuesday 24 September, Alexander Natz, Secretary General of the European Confederation of Pharmaceuticals Entrepreneurs (EUCOPE), sent a letter to the President of the European Commission Ursula von der Leyen, President of the European Parliament Roberta Metsola, and President of the European Council Charles Michel,… read more
The European Confederation of Pharmaceuticals Entrepreneurs (EUCOPE) announced the joining of 7 new members at its quarterly Members Meeting on 18 June 2024, following Board approval. The new members joining the EUCOPE network are Acadia, Edelman Global Advisory, Elevate Bio, GE Healthcare, Regeneron, Rhythm Pharmaceuticals and… read more
At the Employment, Social Policy, Health and Consumer Affairs Council (EPSCO) meeting on 21 June, Health Ministers adopted Council Conclusions on the Future of the European Health Union. Presenting the Council’s perspective on the forthcoming EU health agenda, the Conclusions outline strategic priorities and actions… read more
Keep up-to-date on all of the most pertinent policy files and regulatory news around the world of European health technologies with our monthly newsletter – the Innovation Eye-View
You are currently viewing a placeholder content from Facebook. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.
You are currently viewing a placeholder content from Instagram. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.
You are currently viewing a placeholder content from X. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.
